110 related articles for article (PubMed ID: 37644015)
21. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.
Chen X; Chen J; Yu X; Lin G; Chen T
DNA Cell Biol; 2022 Jul; 41(7):671-682. PubMed ID: 35639418
[TBL] [Abstract][Full Text] [Related]
23. ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.
Pu SY; Yu Q; Wu H; Jiang JJ; Chen XQ; He YH; Kong QP
Oncotarget; 2017 Jun; 8(26):42116-42124. PubMed ID: 28178669
[TBL] [Abstract][Full Text] [Related]
24. CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1.
Li S; Liu N; Piao J; Meng F; Li Y
Onco Targets Ther; 2020; 13():12383-12395. PubMed ID: 33299327
[TBL] [Abstract][Full Text] [Related]
25. ERCC6L promotes cell growth and metastasis in gastric cancer through activating NF-κB signaling.
Chen D; Liu Q; Cao G
Aging (Albany NY); 2021 Aug; 13(16):20218-20228. PubMed ID: 34425559
[TBL] [Abstract][Full Text] [Related]
26. miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1.
Zhou H; Yang L; Xu X; Lu M; Guo R; Li D; Huang Q; Liu Y; Deng G; Xu Y
Oncol Lett; 2019 Jan; 17(1):706-712. PubMed ID: 30655820
[TBL] [Abstract][Full Text] [Related]
27. ERCC6L promotes cell growth and invasion in human colorectal cancer.
Xie Y; Yu J; Wang F; Li M; Qiu X; Liu Y; Qi J
Oncol Lett; 2019 Jul; 18(1):237-246. PubMed ID: 31289493
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of FOXM1 as a target for malignant progression of esophageal squamous cell carcinoma.
Song L; Wang X; Feng Z
Oncol Lett; 2018 Apr; 15(4):5910-5914. PubMed ID: 29552222
[TBL] [Abstract][Full Text] [Related]
29. KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo.
Yang GH; Ren ZX; Yang X; Zhang YG
Onco Targets Ther; 2020; 13():2667-2676. PubMed ID: 32280241
[TBL] [Abstract][Full Text] [Related]
30. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
[TBL] [Abstract][Full Text] [Related]
32. Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCC.
Zhang Y; Liu S; Qu D; Wang K; Zhang L; Jing X; Li C; Wei F; Qu X
Sci Rep; 2017 May; 7(1):2226. PubMed ID: 28533507
[TBL] [Abstract][Full Text] [Related]
33. MiRNA-134 suppresses esophageal squamous cell carcinoma progression by targeting FOXM1.
Yuan Y; Wang Q; Cao F; Han B; Xu L
Int J Clin Exp Pathol; 2019; 12(6):2130-2138. PubMed ID: 31934035
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
Ma J; Qi G; Li L
Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
[TBL] [Abstract][Full Text] [Related]
35. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
[TBL] [Abstract][Full Text] [Related]
36. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
[TBL] [Abstract][Full Text] [Related]
37. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
[TBL] [Abstract][Full Text] [Related]
38. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
Zhang J; An L; Zhao R; Shi R; Zhou X; Wei S; Zhang Q; Zhang T; Feng D; Yu Z; Wang H
Mol Carcinog; 2023 Mar; 62(3):303-318. PubMed ID: 36468837
[TBL] [Abstract][Full Text] [Related]
39. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
40. The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.
Liu G; Lu Y; Li L; Jiang T; Chu S; Hou P; Bai J; Chen M
Invest New Drugs; 2020 Dec; 38(6):1730-1742. PubMed ID: 32533288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]